⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AIM News
AIM ImmunoTech Inc.
AIM ImmunoTech Announces Commencement of Rights Offering
globenewswire.com
AIM
JTC Team Companies to Present in Webull Corporate Connect Webinar Series Happening February 10-11, 2026
accessnewswire.com
AKTX
DCOY
GRI
MBRX
AIM
BULL
AIM ImmunoTech to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
globenewswire.com
AIM
AIM ImmunoTech Reports Positive Year-End Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
globenewswire.com
AIM
AIM Sports Group Enhances AIM Sportsplex with Spiideo’s Advanced Automated Video Technology
businesswire.com
AIM
AIM ImmunoTech Announces Changes to Key Dates and Terms Related to Announced Rights Offering
globenewswire.com
AIM
AIM ImmunoTech Announces Key Dates and Terms Related to Announced Rights Offering
globenewswire.com
AIM
AIM ImmunoTech Announces Stock Dividend
globenewswire.com
AIM
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B
prnewswire.com
ONCY
AVBP
MRUS
HALO
AIM
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
globenewswire.com
AIM